DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CBV (chemotherapy)
CBV (chemotherapy)
New Brunswick Prescription Drug Program Formulary
Biomarkers in Glioblastoma HIVE
Kepivance, INN-Palifermin
High-Dose Carmustine, Etoposide, and Cyclophosphamide Followed by Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma
Bicnu (Carmustine)
Appendix C Medication Tables
DRUG NAME: Cyclophosphamide
Aspects Anatomocliniques Et Évolutifs
Autologous Stem Cell Transplantation for High-Risk Hodgkin's Disease
(12) United States Patent (10) Patent No.: US 6,911,200 B2 Yu Et Al
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
Chemotherapy Drugs
Carmustine Replacement in Intensive Chemotherapy Preceding Reinjection of Autologous Hscs in Hodgkin and Non-Hodgkin Lymphoma: a Review
Research Article Effects of Rutin and Quercetin on Doxorubicin-Induced
Protocol No. I 72806 Page 1 of 73 Date: Feb 6, 2018
A Randomized Trial of Amifostine and Carmustine-Containing Chemotherapy to Assess Lung-Protective Effects
Public Assessment Report
Semen Quality in Men with Malignant Diseases Before and After Therapy and the Role of Cryopreservation
Top View
Carmustine Obvius 100 Mg Powder and Solvent for Concentrate for Solution for Infusion
(12) Patent Application Publication (10) Pub. No.: US 2015/0322155A1 Zhao (43) Pub
(12) United States Patent (10) Patent No.: US 6,319,682 B1 Hochman (45) Date of Patent: *Nov
University of Shendi Faculty Graduate Studies and Scientific Research
An Inverse Switch in DNA Base Excision and Strand Break Repair Contributes to Melphalan Resistance in Multiple Myeloma Cells
PRODUCT MONOGRAPH Prprocytox
(BGP) User Manual
Oral Presentations 01 Medulloblastoma/Cns-Pnet—Biology
Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia And
Incidence and Characterization Of
(12) United States Patent (10) Patent No.: US 6,573,063 B2 Hochman (45) Date of Patent: *Jun
Current Topics in Medicinal Chemistry, 2016, 16, 2432-2440
Chemotherapy Drugs
Core Measures ALQIO.Indd
Modified Conditioning Regimen with Idarubicin Followed by Autologous
Du Nouveau Contre Les Nausées Et Vomissements Induits Par La Chimiothérapie Et La Radiothérapie
Non-Hodgkin's Lymphoma Autologous Stem Cell Transplantation
International Patent Classification
Care of the Pediatric Patient with a Brain Tumor
©Ferrata Storti Foundation
For Lymphoma: Re- Review
CBV) Conditioning Before Allogeneic Stem Cell Transplantation for Patients with Non-Hodgkin’S Lymphoma
Lymphoma High-Dose Therapy and Autologous Stem Cell Transplantation in Relapsing Cutaneous Lymphoma
Strategies to Improve Outcomes of Autologous Hematopoietic Cell Transplant in Lymphoma
Contents ABVD
Modi Ed BEAC Conditioning Regimen with Idarubicin Followed by Autologous Hematopoietic Stem Cell Transplantation Is Safe And
Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory Or Relapsed Lymphoma: Results of Children’S Oncology Group Study A5962 Richard E
(Cyclophosphamide, Bendamustine and Etoposide) Pre-Autotransplant Conditioning in Persons with Lymphoma
Fatigue Chronique Chez Les Survivants D'un Lymphome
Repriming by Primpol Is Critical for DNA Replication Restart Downstream of Lesions and Chain-Terminating Nucleosides
BCNU) and Etoposide (VP16-213) (CBV) and CBV Plus Cisplatin (CBVP) Followed by Autologous Stem Cell Transplantation in Patients with Hodgkin’S Disease